ArticleFamily practice2020

Is polypharmacy beneficial or detrimental for older adults with cardiometabolic multimorbidity? Pooled analysis of studies from Hong Kong and Europe.

Johnny T K Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.